LMDX LumiraDx Limited

$LMDX Ron Zwanziger reportedly expanded his personal equity ownership of the legacy LMDX shell to roughly 25–28% (plus family owned) post-liquidation. Because he holds massive voting leverage over the legacy shell and controls ElectraDx, there is zero friction or competing corporate resistance to a merger. Because the DTCC never officially issued a zero-value cancellation notice on LMDXF, the ticker is "chilled" on the OTC Expert Market. Short sellers are paying massive daily borrow fees. Reinstating the shell through a reverse succession would trigger a forced short cover, providing instant market liquidity. The Tech Mastermind: ElectraDx’s CEO, Jarrod Provins, was the former head of R&D at LumiraDx and the lead inventor of the qSTAR amplification technology. • The Lab Footprint: ElectraDx UK Ltd established its R&D headquarters at Maxim Park in Motherwell, Scotland—the exact same regional hub where LumiraDx built its core point-of-care operations.

$LMDX Facts:This would be the first aquisition by ROCHE in history, of an public traded companie, were shareholders aren't settled and wipped out. What are the odds?

$LMDX is this the fake 13 Geo13 because all years past you were talking about it’s gonna be this month no next month trying to be positive. You had gave me hope sometimes. Just sucks to see you’ve given up. I’m still a bull until they take my shares

$LMDX Update on trial for Ryan's wife. It will be moved to March 1, 2027. It's as unending as this LMDX saga. DA says it will be prioritized this time so they can put her away. I don't trust that last message. I think it is a fake and not from George. But who am I to know. Let's have a good day anyway.

$LMDX times like this I wish Ryan was here to do some digging and bring a bit more relative clarity. RIP 🙏 guy was a monster when it came to research

$LMDX Exactly. There is no way I'm going to forfeit my shares for a $5000 tax. Write off how I see it is the money's already spent, and I'll wait as long as I have to for the outcome there is too much evidence proving that a payout will happen. Ryan would want it that way.!!! So i'm gonna continue on and wait for the universe to bless us all!

$LMDX If we look at this through the lens of a highly complex restructuring maneuver rather than a bankruptcy: For Ron Zwanziger to successfully execute a Form 8-K Succession, the old shell has to remain intact. If the restructuring officer successfully navigates the remaining creditor objections in the Cayman Grand Court, that old CUSIP will serve as the literal vehicle for an equity exchange or distribution relating to the new entity (ElectraDx). Brokers refuse to touch the shares because if an equity swap, tracking distribution, or structural assignment drops out of the Cayman court proceedings, any broker that deleted the CUSIP would face massive liability for erasing a client's claim to that succession.

$LMDX Basically there are no more dates and they are free to move forward with the Cayman Admin's blessing. If they resurrect the shell as expected it will most likely happen between now and February .

$LMDX ✅ 1. Legacy (Pre-Feb 1) Shares are the Golden TicketIn a typical bankruptcy administration, old common shares are wiped out. However, because ElectraDx Molecular LLC was founded by former LumiraDx leadership (including Zwanziger), using a legal petition to void the dissolution ab initio (from the beginning) allows them to maintain the shell's corporate personality.By structuring the succession so that pre-Feb 1 shares convert, the insiders are directly protecting their own multi-million dollar legacy cost-basis and equity stakes.Retail investors who held their original, pre-Feb 1 legacy shares through the delisting would be carried along for the ride, directly participating in the transition to the new company rather than getting wiped out.

$LMDX Market Anomaly Operational Impact on LMDXF The Trading Chill Lift While trading is locked on the Expert Market, short sellers cannot easily buy to cover. The moment the DTCC lifts the chill to process a new legal framework, a massive, backlogged queue of buy-to-cover orders is unleased onto the open market. Instant Order Book Vacuum Retail investors own nearly 100% of the active public float, and insiders like Ron Zwanziger lock up another massive chunk. If retail investors refuse to sell their shares at pennies, there are zero institutional block shares available to absorb short-cover buy orders, causing the ask price to gap upward violently. Forced DTCC Liquidation If the reverse merger alters the underlying equity structure (such as changing the CUSIP code or re-listing on an active exchange), clearing brokers can mandate a forced reconciliation. Short sellers are forced to close their open borrows at any available market price to prevent systemic clearing house failures.

$LMDX Thank you for your patience while waiting, George. I have thoroughly checked our internal records, the Corporate Events platform, and the verified status with our executing broker, DriveWealth: **DriveWealth & Depository Verification (CUSIP G5709L109):** DriveWealth, which is a direct participant with DTCC, confirms that there is no active, pending, or scheduled corporate action for LumiraDx (LMDX / CUSIP G5709L109). This means there are no settlement instructions, cash merger payouts ($35.26), or share distributions available. The transaction between Roche and LumiraDx was an asset sale completed during administration proceedings, where all proceeds were legally allocated to senior secured creditors, leaving no distribution for common shareholders. **Regarding Previous Chat Confirmations:** As mentioned by our Duty Managers, the previous references to a $35.26 cash payout or DTCC allocations were sent in error based on unverified information and have been formally retract

$LMDX We could see this thing finalize by Halloween. I hope it will happen by Thanksgiving. I believe it will happen by Christmas for sure. And if it doesn’t happen by the end of February, I’ll begin to wonder if it ever will. 🧌 And I still believe it will end very well for us all, we that are long anyway. My hope is for a minimum of $10 per share!

$LMDX if someone receives a payout or any solid news pls tag me. Until then have a nice life 😌

$LMDX just like MMTLP, and many others, the shares have been washed multiple times and moved off-shore, have fun with your tier 1 and tier 2 shareholder theory. The efforts to get people to take a tax write-off tells me exactly who you are. Nobody can sell, so you are reaching hard on this one.

$LMDX shills talking amongst themselves again 😩 Always saying "we" to drum up collective sentiment. It will be a fruitful new year.

$LMDX I don't know why some are focused on a 2027 note that seems to no longer exist. Now that the warrants are out of the way, the time for final resolution is NOW!

$LMDX More interesting: a NEW filing today from TAUNS Today, September 24, TAUNS Laboratories filed its FY2026 annual report. The filing explicitly confirms that TAUNS owns 1,000 ElectraDx shares, carried at ¥1.187668 billion on its balance sheet.

$LMDX Could mean something, could mean nothing. This latest days brokers Ai chat bot consequently suggests shares distribution of Roche for the entitled LMDX shareholders 1:1.And $54, 15 is the price of $RHHBY today. Will see if anything happens. Is anyone else that is constantly(weekly) checking with brokers compliance team and chats about whats going on?

$LMDX Multiple rules would have been broken for allowing purchases post Feb 1st, so the brokers would be legally required to refund the money. It could not be seen as a glitch since the multiple purchases were made, and should have been flagged multiple times. Ignoring multiple flags is a breach of fiduciary duty. It's an easy open and shut case. Thank for coming out with your theories, but I can also use AI. It's either win or refund. Those are the only 2 options.

$LMDX Hmmm…so it seems the court may alter the record date of the company is reinstated into a new structural entity. It seems to me the initial record date simply is a mechanism by which the transfer of shares “debt” enabled the Roche acquisition all those going on about a price of$35. 26 or whatever in DTCs system that price simply reflects the price paid to LmDX 395 mil or whatever divided by the number of shares in that tfr it’s not even payable to shareholders. I could be wrong anyone?